1. Home
  2. APLS vs EPAC Comparison

APLS vs EPAC Comparison

Compare APLS & EPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • EPAC
  • Stock Information
  • Founded
  • APLS 2009
  • EPAC 1910
  • Country
  • APLS United States
  • EPAC United States
  • Employees
  • APLS N/A
  • EPAC N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • EPAC Industrial Machinery/Components
  • Sector
  • APLS Health Care
  • EPAC Technology
  • Exchange
  • APLS Nasdaq
  • EPAC Nasdaq
  • Market Cap
  • APLS 2.3B
  • EPAC 2.1B
  • IPO Year
  • APLS 2017
  • EPAC N/A
  • Fundamental
  • Price
  • APLS $17.30
  • EPAC $43.37
  • Analyst Decision
  • APLS Buy
  • EPAC Buy
  • Analyst Count
  • APLS 19
  • EPAC 1
  • Target Price
  • APLS $39.06
  • EPAC $53.00
  • AVG Volume (30 Days)
  • APLS 2.7M
  • EPAC 254.9K
  • Earning Date
  • APLS 05-07-2025
  • EPAC 06-23-2025
  • Dividend Yield
  • APLS N/A
  • EPAC 0.09%
  • EPS Growth
  • APLS N/A
  • EPAC 35.24
  • EPS
  • APLS N/A
  • EPAC 1.70
  • Revenue
  • APLS $775,839,000.00
  • EPAC $599,828,000.00
  • Revenue This Year
  • APLS $12.25
  • EPAC $7.32
  • Revenue Next Year
  • APLS $21.08
  • EPAC $6.79
  • P/E Ratio
  • APLS N/A
  • EPAC $25.61
  • Revenue Growth
  • APLS 48.04
  • EPAC 0.43
  • 52 Week Low
  • APLS $16.65
  • EPAC $35.18
  • 52 Week High
  • APLS $43.99
  • EPAC $51.91
  • Technical
  • Relative Strength Index (RSI)
  • APLS 34.14
  • EPAC 60.71
  • Support Level
  • APLS $16.65
  • EPAC $41.15
  • Resistance Level
  • APLS $20.75
  • EPAC $43.84
  • Average True Range (ATR)
  • APLS 1.09
  • EPAC 1.03
  • MACD
  • APLS 0.14
  • EPAC 0.55
  • Stochastic Oscillator
  • APLS 15.85
  • EPAC 92.47

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About EPAC Enerpac Tool Group Corp.

Enerpac Tool Group Corp provides high-precision tools, controlled-force products, and solutions for precise heavy lifting. The company has one reportable segment, the Industrial Tools & Services (IT&S) Segment. The IT&S segment is engaged in the design, manufacture, and distribution of branded hydraulic and mechanical tools and in providing services and tool rental to the refinery/petrochemical; general industrial; industrial maintenance, repair, and operations (MRO); machining & manufacturing; power generation; infrastructure; mining; and other markets. Geographically, the company has operations in Algeria, Australia, Brazil, France, Germany, Kazakhstan, India, Italy, Japan, Norway, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Spain, and the United Arab Emirates.

Share on Social Networks: